8
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found

      Cushing’s Syndrome: Current Status

      research-article
      Cardiology
      S. Karger AG
      Cushing’s syndrome, Pituitary tumour, Orticotroph, Hypercortisolaemia, Dyspituitarism

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The evolution of ideas concerning the aetiology of Cushing’s syndrome over the past 70 years is reviewed briefly. It is now agreed that about 70% of patients have a pituitary adenoma, not necessarily basophil, the removal of which results in remission but follow-up is currently too short for assessment of ultimate cure. Whether or not the pituitary lesion is primary or secondary to events in the cerebrum or brainstem is discussed, but a definite answer cannot be given at present.

          Related collections

          Author and article information

          Journal
          CRD
          Cardiology
          10.1159/issn.0008-6312
          Cardiology
          S. Karger AG
          978-3-8055-4079-7
          978-3-318-00139-6
          0008-6312
          1421-9751
          1985
          1985
          11 November 2008
          : 72
          : Suppl 1
          : 64-69
          Affiliations
          Department of Medicine, Faculty of Clinical Sciences, University College London, School of Medicine, London, UK
          Article
          173947 Cardiology 1985;72:64–69
          10.1159/000173947
          3876884
          67686e10-379e-4237-906e-3f7158bf5ce2
          © 1985 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          History
          Page count
          Pages: 6
          Categories
          Paper

          General medicine,Neurology,Cardiovascular Medicine,Internal medicine,Nephrology
          Hypercortisolaemia,Pituitary tumour,Cushing’s syndrome,Orticotroph,Dyspituitarism

          Comments

          Comment on this article